Cure Alzheimer's Fund Cure Alzheimer's Fund

Liisa Galea, Ph.D.

Treliving Chair in Women’s Mental Health, Centre for Addiction and Mental Health, Canada; Professor, University of Toronto

Dr. Liisa Galea is the Treliving Family Chair in Women’s Mental Health at the Centre for Addiction and Mental Health and a Professor in the Department of Psychiatry at the University of Toronto. She leads the Women’s Health Research Cluster with over 950 members across 41 countries, a dedicated network to promote and catalyze impactful women’s health research. Dr. Galea is a world-renowned expert in sex and sex hormone influences on the brain, with a focus on stress-related psychiatric disorders and dementia. She has more than 220 published scientific papers and is a Fellow of the Canadian Academy of Health Sciences and a Top 25 Women of Influence in Canada in 2025.

Dr. Galea has won numerous awards, including the Mortyn Jones Medal and the 2015 Vancouver YMCA woman of distinction for science. She has served on peer review committees for Canadian, American, and British federal funding agencies and on health and science advisory boards provincially, nationally, and internationally (Switzerland, Italy, Germany and the US). She is the principal editor of a leading journal in neuroendocrinology and serves on 5 editorial boards for academic neuroscience journals. Dr. Galea is in the top 1% of cited researchers worldwide. She is a tireless advocate for women’s health research and for sex and gender-based analyses towards improved health for all.

Follow Dr. Galea and her lab on:

X (Twitter): @LiisaGalea

LinkedIn

Instagram

Bluesky

Related Research:

Unravelling Precision Hormone Therapy Using Menopause and Hormone Therapy Type Across APOE Genotype Liisa Galea Annie Ciernia 2025-12-01 Combined Hormone Therapy as a Novel Treatment for Alzheimer’s Disease in the Face of a Metabolic Challenge: Influence of Sex and Genotype Liisa Galea Annie Ciernia 2024-08-19 Sex Matters: Understanding the Influence of Sex and Apolipoprotein E (APOE) Genotype on Hippocampal Plasticity and Cognition Liisa Galea 2020-11-11

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Unravelling Precision Hormone Therapy Using Menopause and Hormone Therapy Type Across APOE Genotype 2025

$201,250

Combined Hormone Therapy as a Novel Treatment for Alzheimer’s Disease in the Face of a Metabolic Challenge: Influence of Sex and Genotype 2022, 2024

$402,500
Sex Matters: Understanding the Influence of Sex and Apolipoprotein E (APOE) Genotype on Hippocampal Plasticity and Cognition 2020, 2022

$342,700

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Richard, J. E., Mohammad, A., Go, K. A., McGovern, A. J., Rechlin, R. K., Splinter, T. F. L., Lieblich, S. E., Radovic, L. K., Feng, L., Blankers, S. A., Yang, B., Douros, J. D., Finan, B., & Galea, L. A. M. Sex-specific metabolic and central effects of GLP-1–estradiol conjugate in middle-aged rats on a standard or western diet, Brain, Behavior, and Immunity, August 23, 2025, Read More

Dhamala, E., Ricard, J. A., Uddin, L. Q., Galea, L. A. M., Jacobs, E. G., Yip, S. W., Yeo, B. T. T., Chakravarty, M. M., & Holmes, A. J. Considering the interconnected nature of social identities in neuroimaging research, Nature Neuroscience, December 27, 2024, Read More

Back to Our Researchers